Projects per year
Personal profile
Biography
Christoph Hagemeyer, a chemist by training, obtained a PhD in Biochemistry from the University of Freiburg (Germany). He made contributions to the field of Cytochrome P450 metabolism in the rodent brain before moving into cardiovascular research developing anti-thrombotic recombinant fusion proteins and novel imaging probes. He migrated to Australia in 2005 and is currently Head of the NanoBiotechnology Laboratory at Monash University’s Australian Centre for Blood Diseases. His main research interests are drug delivery, molecular imaging and novel bioconjugation techniques in thrombosis, inflammation and cancer.
Monash teaching commitment
HUP3011 - Human pathology: Atherosclerosis
HUP3011 - Human pathology: Vascular biology and disease
IMM3042 - Clinical immunopathology: Recombinant antibodies in immunotherapy
Central Clinical School Honours program "Molecular Imaging Technology"
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Chemistry, PhD, Cytochrome P450 in the brain , Albert Ludwigs Universitat Freiburg (Albert Ludwig University of Freiburg)
Award Date: 1 Jun 2001
Chemistry, MSc, Cytochrome P450 in the brain, Albert Ludwigs Universitat Freiburg (Albert Ludwig University of Freiburg)
Award Date: 1 Apr 1997
External positions
President, Australian Society for Medical Research (ASMR)
22 Nov 2019 → …
NHMRC Senior Research Fellow, NHMRC - National Health and Medical Research Council (Australia)
1 Jan 2019 → 31 Dec 2023
A/Prof, RMIT University
1 Mar 2014 → …
Research area keywords
- PET CT
- acute MI
- animal models of human disease
- antibodies
- arterial thrombosis
- drug delivery systems
- microbubbles
- molecular imaging
- platelets
- thrombosis
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
DECIPHER : DECIPHER (Dapagliflozin Effects on Coronary mIcrocalcification, Plaque morpHology, and hEart Remodelling by multimodality imaging)
Lin, A. (Primary Chief Investigator (PCI)), Nerlekar, N. (Chief Investigator (CI)), Nicholls, S. (Chief Investigator (CI)), Hagemeyer, C. (Chief Investigator (CI)) & Tsigaridis, K. (Chief Investigator (CI))
1/07/25 → 31/12/26
Project: Research
-
ARC Training Centre for Development of Advanced Radiochemical Technologies
Robinson, A. (Primary Chief Investigator (PCI)), Donnelly, P. (Chief Investigator (CI)), Rendina, L. (Chief Investigator (CI)), McIntosh, M. (Chief Investigator (CI)), Hagemeyer, C. (Chief Investigator (CI)), Tuck, K. (Chief Investigator (CI)), Andrews, P. (Chief Investigator (CI)), Alt, K. (Chief Investigator (CI)), Ritchie, C. (Chief Investigator (CI)), Turner, D. (Chief Investigator (CI)), Chan, P. W. H. (Chief Investigator (CI)), Aulsebrook, M. (Chief Investigator (CI)), Hutton, C. A. (Chief Investigator (CI)), White, J. M. L. (Chief Investigator (CI)), Rutledge, P. (Chief Investigator (CI)), New, E. (Chief Investigator (CI)), Ackerman, U. (Chief Investigator (CI)), Fraser, B. H. (Partner Investigator (PI)), Greguric, I. (Partner Investigator (PI)), Le, L. (Partner Investigator (PI)), Kopka, K. (Partner Investigator (PI)), Zarschler, K. (Partner Investigator (PI)), Oldham, T. (Partner Investigator (PI)), Santamaria, G. (Partner Investigator (PI)), Walsh, B. (Partner Investigator (PI)), Campbell, D. (Partner Investigator (PI)), Poniger, S. (Partner Investigator (PI)), Wheatcroft, M. (Partner Investigator (PI)), Graf, S. (Partner Investigator (PI)), Toups Dugas, D. (Project Manager) & Lengkeek, N. A. (Partner Investigator (PI))
ARC - Australian Research Council
1/10/24 → 30/09/29
Project: Research
-
Engineering targeted thrombolytic and brain-rejuvenating nano-carriers for the treatment of acute ischemic stroke
Xu, R. (Primary Chief Investigator (PCI)), Hagemeyer, C. (Chief Investigator (CI)) & Niego, B. (Chief Investigator (CI))
1/01/23 → 31/07/27
Project: Research
-
Molecular Imaging of Cardiac Fibrosis in Atrial Fibrillation, Heart Failure and Myocardial Infarction
Niego, B. (Primary Chief Investigator (PCI)), Alt, K. (Chief Investigator (CI)) & Hagemeyer, C. (Chief Investigator (CI))
National Heart Foundation of Australia
1/01/23 → 31/12/24
Project: Research
-
Near Infrared Fluorescence and Photoacoustic Imaging Facility
Egan, G. (Primary Chief Investigator (PCI)), Bansal, V. (Chief Investigator (CI)), Wood, B. (Chief Investigator (CI)), Boyer, C. (Chief Investigator (CI)), Voelcker, N. (Chief Investigator (CI)), Cavalieri, F. (Chief Investigator (CI)), Hagemeyer, C. (Chief Investigator (CI)) & Corrie, S. (Chief Investigator (CI))
26/10/22 → 25/10/23
Project: Research
-
Collagen-targeted tracers for molecular imaging of atrial fibrosis and sensitive detection of atrial fibrillation
Niego, B. (Leading Author), Hagemeyer, C. (Leading Author), Jupp, B., Noor, A., Donnelly, P., Xu, R., Mendis, T., Chen, Y. C., Carmichael, I., McMullen, J. (Leading Author) & Alt, K. (Leading Author), 6 Oct 2025, In: npj Cardiovascular Health. 2, 13 p., 49.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Development and Evaluation of a Novel Drainage Cannula for Venoarterial Extracorporeal Membrane Oxygenation
Wickramarachchi, A., Shirejini, S. Z., Vatani, A., Rana, A., Khamooshi, M., Šeman, M., Liao, S., Jap, E., Nguyen, T. H., Alt, K., Burrell, A., Pellegrino, V. A., Kaye, D. M., Hagemeyer, C. E. & Gregory, S. D., Mar 2025, In: ASAIO Journal. 71, 3, p. 235-244 10 p.Research output: Contribution to journal › Article › Research › peer-review
-
Nanotherapeutics in Kidney Disease
Roointan, A., Xu, R., Corrie, S., Hagemeyer, C. E. & Alt, K., Mar 2025, In: Journal of the American Society of Nephrology. 36, 3, p. 500-518 19 p.Research output: Contribution to journal › Review Article › Research › peer-review
Open Access9 Citations (Scopus) -
Thrombolytic drugs for ischemic stroke: Historical perspective, State of play and future developments
Walie, B. E. (Leading Author), Hagemeyer, C., Xu, R. & Niego, B. (Leading Author), Oct 2025, (Accepted/In press) In: Journal of Thrombosis and Thrombolysis. 38 p., JTHA-D-25-00498R1.Research output: Contribution to journal › Review Article › Research › peer-review
Open Access -
Cell membrane surface-engineered nanoparticles for cardiovascular diseases
Motlagh, N. V., Rahmani, R., Dua, K. & Hagemeyer, C., 2024, Cell Membrane Surface-Engineered Nanoparticles: Biomimetic Nanomaterials for Biomedical Applications. Paiva-Santos, A. C., Rabiee, N. & Makvandi, P. (eds.). 1st ed. USA: American Chemical Society, p. 193-216 24 p. (ACS Symposium Series; vol. 1464).Research output: Chapter in Book/Report/Conference proceeding › Chapter (Book) › Other › peer-review
1 Citation (Scopus)
Activities
-
Biochemistry & Molecular Biology (Organisational unit)
Law, R. (Inventor), Whisstock, J. (Inventor), Quek, A. (Contributor), Hagemeyer, C. (Contributor), Martino, M. (Contributor), Wu, J. (Contributor) & Lu, A. (Contributor)
2022Activity: Industry, Government and Philanthropy Engagement and Partnerships › Patents › Patent (Provisional)
-
Submission to the senate inquiry for the Higher Education Support Amendment (Job-ready Graduates and Supporting Regional and Remote Students) Bill 2020 from The Australian Society for Medical Research (ASMR)
Hagemeyer, C. (Fellow), Davis, R. (Fellow), Johnstone, D. (Fellow) & Beilby, K. (Fellow)
9 Sept 2020Activity: External Academic Engagement › Submissions to industry or govt committees, commissions and inquiries
-
Cardiovascular Therapeutics (Journal)
Hagemeyer, C. (Associate editor)
2014 → …Activity: Publication peer-review and editorial work types › Editorial responsibility
-
PLoS ONE (Journal)
Hagemeyer, C. (Associate editor)
2013 → …Activity: Publication peer-review and editorial work types › Editorial responsibility
Equipment
-
Monash Biomedical Imaging (MBI)
Reid, K. (Manager), Brkljaca, R. (Manager), Hagemeyer, C. (Other) & Wright, D. (Other)
Office of the Vice-Provost (Research and Research Infrastructure)Facility/equipment: Facility